Fakeeh Care clarified the parties and ownership structure involved in its acquisition of a 50.01% stake in Diagnostics Elite
Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) said that Diagnostics Elite acquisition deal includes itself as the buyer and Fakeeh Real Estate as a seller, according to a statement to Tadawul. 
Diagnostics Elite’s current shareholders are Fakeeh Real Estate (owns 30,510 shares out of 61,000 issued shares, or 50.01% of capital), and the founders (six radiology consultants who collectively hold 30,494 shares, or 49.99% of capital).
On Dec. 2,Fakeeh Careacquired a 50.01% stake in Diagnostics Elite Co., a Saudi-based teleradiology and imaging services company, for SAR 70 million (aggregate of purchase consideration and capital contribution), data compiled by Argaam showed.
Fakeeh Care will purchase from Soliman Abdel Kader Fakeeh Real Estate Co. Ltd.—0.01%-owned by Fakeeh Care Group—30,506 shares of Diagnostics Elite, representing 50.01% of the company’s issued share capital, without profit to the seller. The remaining 49.99% shares will be held by the existing founding shareholders of the company.
Fakeeh Care clarified the parties and ownership structure involved in its acquisition of a 50.01% stake in Diagnostics Elite
Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) said that Diagnostics Elite acquisition deal includes itself as the buyer and Fakeeh Real Estate as a seller, according to a statement to Tadawul.
Diagnostics Elite’s current shareholders are Fakeeh Real Estate (owns 30,510 shares out of 61,000 issued shares, or 50.01% of capital), and the founders (six radiology consultants who collectively hold 30,494 shares, or 49.99% of capital).
On Dec. 2,Fakeeh Careacquired a 50.01% stake in Diagnostics Elite Co., a Saudi-based teleradiology and imaging services company, for SAR 70 million (aggregate of purchase consideration and capital contribution), data compiled by Argaam showed.
Fakeeh Care will purchase from Soliman Abdel Kader Fakeeh Real Estate Co. Ltd.—0.01%-owned by Fakeeh Care Group—30,506 shares of Diagnostics Elite, representing 50.01% of the company’s issued share capital, without profit to the seller. The remaining 49.99% shares will be held by the existing founding shareholders of the company.
